Federal Register of Legislation - Australian Government

Primary content

PB 92 of 2022 Arrangements as made
This instrument amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015) to include provision for the supply of two new medicines (mecasermin and somatrogon) for the treatment of children with particular conditions, consistent with recommendations of the Pharmaceutical Benefits Advisory Committee made in March 2022.
Administered by: Health and Aged Care
Registered 26 Sep 2022
Tabling HistoryDate
Tabled HR27-Sep-2022
Tabled Senate28-Sep-2022
Date of repeal 08 Feb 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Help with file formats Help with file formats
Legislative Instrument
F2022L01250 : Authoritative PDF Document : 0.7MB Primary Document Icon F2022L01250 : ZIP Document : 88KB
9 pages

Explanatory Statement
F2022L01250ES : PDF Document : 0.7MB Primary Document Icon F2022L01250ES : ZIP Document : 32KB
7 pages